BioVie

-$0.02 (-0.79%) As of 6:36 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioVie and other ETFs, options, and stocks.

About BIVI

BioVie, Inc. is a biopharmaceutical company, which discovers, develops and commercializes drug therapies for liver disease. It focuses on BIV201, which treats ascites due to chronic liver cirrhosis.

CEO
Cuong Viet Do
Employees
—
Headquarters
Santa Monica, California
Founded
2013

BIVI Key Statistics

Market cap
62.96M
Price-Earnings ratio
—
Dividend yield
—
Average volume
24.21K
High today
$2.60
Low today
$2.50
Open price
$2.57
Volume
28.81K
52 Week high
$19.10
52 Week low
$2.50

BIVI Earnings

-$10.18
-$6.79
-$3.39
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected Aug 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure